Literature DB >> 24315048

Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA.

Maria D Mjaavatten1, Vivian P Bykerk.   

Abstract

New classification criteria for rheumatoid arthritis (RA) were presented by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) in 2010, aiming for early identification of patients at risk of developing persistent and erosive arthritis. Since their publication, the criteria have been extensively validated against several reference standards, but there is still debate regarding how the criteria should be implemented in studies and clinical care. We present an overview of the published validation studies and discuss the strengths and limitations of the classification criteria, as well as whether the criteria are ready for diagnostic purposes in clinical practice.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Classification; Criteria; Early diagnosis; Rheumatoid arthritis; Sensitivity; Specificity

Mesh:

Substances:

Year:  2013        PMID: 24315048     DOI: 10.1016/j.berh.2013.09.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  13 in total

1.  The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.

Authors:  Khalid Almutairi; Johannes Nossent; David Preen; Helen Keen; Charles Inderjeeth
Journal:  Rheumatol Int       Date:  2020-11-11       Impact factor: 2.631

Review 2.  The use and abuse of diagnostic/classification criteria.

Authors:  Rayford R June; Rohit Aggarwal
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-23       Impact factor: 4.098

3.  Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study.

Authors:  Yunyun Xu; Hongjun He; Yinshan Zang; Zhe Yu; Huaixia Hu; Jiajia Cui; Wenwen Wang; Yingying Gao; Hua Wei; Zhuqing Wang
Journal:  Clin Rheumatol       Date:  2022-03-09       Impact factor: 2.980

4.  Expression of miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded synovial tissues of patients with rheumatoid arthritis and osteoarthritis.

Authors:  Mark Kriegsmann; Thomas M Randau; Sascha Gravius; Katharina Lisenko; Carolin Altmann; Norbert Arens; Jörg Kriegsmann
Journal:  Virchows Arch       Date:  2016-04-14       Impact factor: 4.064

5.  Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis.

Authors:  Ismet H Bajraktari; Sylejman Rexhepi; Idriz Berisha; Ali Lahu; Avni Kryeziu; Bastri Durmishi; Halit Bajraktari; Elton Bahtiri
Journal:  Open Access Maced J Med Sci       Date:  2017-08-10

6.  Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

Authors:  Cristina Regueiro; Laura Nuño; Ana M Ortiz; Diana Peiteado; Alejandro Villalba; Dora Pascual-Salcedo; Ana Martínez-Feito; Isidoro González-Alvaro; Alejandro Balsa; Antonio González
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  Diagnostic Accuracy of Anticarbamylated Protein Antibodies in Established Rheumatoid Arthritis: A Monocentric Cross-Sectional Study.

Authors:  G L Erre; N Mundula; E Colombo; A A Mangoni; L A Sechi; M Oggiano; R Irde; A Zinellu; G Passiu; C Carru
Journal:  ACR Open Rheumatol       Date:  2019-08-08

8.  Association of cytokine patterns and clinical/laboratory parameters, medication and periodontal burden in patients with rheumatoid arthritis (RA).

Authors:  S Patschan; L Bothmann; D Patschan; E Henze; G Schmalz; O Ritter; D Ziebolz
Journal:  Odontology       Date:  2020-04-16       Impact factor: 2.634

Review 9.  Rheumatoid arthritis in Saudi Arabia.

Authors:  Hani M Almoallim; Laila A Alharbi
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

10.  Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren's syndrome treated with Infliximab: a pilot study.

Authors:  L K Anzola-Fuentes; M Chianelli; F Galli; A W J M Glaudemans; L Martin Martin; V Todino; A Migliore; A Signore
Journal:  EJNMMI Res       Date:  2016-06-04       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.